my first black bear siting in squamish

May 26, 2007

took place today.  It looked like a mama bear in size.  She/he was running across the road in suburban Squamish. 

Simple Strawberry Cream Freeze

May 25, 2007
Inspired by Simple Food for the Good Life, by Helen Nearing (Chelsea Green, 1999).

INGREDIENTS

1 quart strawberries (you could also substitute blueberries or raspberries)
1/2 cup maple syrup
2 cups plain Greek-style yogurt
1 cup organic sour cream

1. Mash berries and combine with maple syrup. Fold in the yogurt and sour cream.

2. Place mixture in a shallow pan and put in freezer. Stir every half-hour for 2 hours, then serve.

Serves 6 to 8.

from http://www.care2.com/greenliving/3403.html?print=1

This looks very yummy ….

Recipe - Simple Cucumber Salad Trio

Inspired by Simply in Season, by Mary Beth Lind and Cathleen Hockman-Wert (Herald Press, 2005).


 

INGREDIENTS

3 cups thinly sliced cucumbers
1/2 cup thinly sliced onion (Vidalia are nice)

Salad 1

1. Put the cucumbers and onion in a bowl and sprinkle with 1 teaspoon salt. Allow to stand 1 hour, then drain off liquid.

2. In a saucepan, place:

1/3 cup organic sugar
1/4 cup organic apple cider vinegar
1/2 teaspoon celery seed

3. Bring to a boil and cook until sugar is dissolved. Pour this dressing over the drained cucumbers and onions, cover, and chill in fridge several hours, oor overnight. This salad will keep for several days.

Salad 2

1. In a bowl, mix:

2 tablespoons extra-virgin olive oil
1/2 teaspoon seasalt
1 tablespoon organic sugar

2. Add to cucumbers and onions and toss to mix.

Salad 3

1. Place cucumbers and onions in a bowl and sprinkle with 1 teaspoon salt. Allow to stand for 1 hour, then drain off liquid.

Add to the cucumbers and onions:

3/4 cup plain yogurt
1 tablespoon chopped fresh mint or dill weed

Each version serves 4.

Prostate Cancer Advocates Unite to Fight for Immediate FDA Approval of First-of-Its-Kind Cancer Vaccine — Unprecedented “ProvengeNow” Coalition to assemble on Capitol Hill — (article url)

May 24, 2007

Press Release - ProvengeNow……

Prostate Cancer Advocates Unite to Fight for Immediate FDA Approval of First-of-Its-Kind Cancer Vaccine
– Unprecedented “ProvengeNow” Coalition to assemble on Capitol Hill —

NEW YORK–(BUSINESS WIRE)–Patients, survivors, physicians and caregivers have formed a coalition called ProvengeNow to fight the recent decision by the U.S. Food and Drug Administration to delay the approval of a new and safe immunotherapy vaccine treatment, until more data becomes available in 2010.

Advocates that are a part of this initiative thus far include: Us TOO! International, The Prostate Health Education Network (PHEN), Prostate Cancer Research Institute, Malecare, Survivors Celebration, Raise a Voice, Patient Advocate for Advanced Cancer Treatments (PAACT) along with prostate cancer expert Mark A. Moyad, M.D., M.P.H.

With chemotherapy as the only available treatment for men with advanced, hormone-refractory prostate cancer, members of ProvengeNow hope to extend the lives of these patients and also give them a better quality of life with this new landmark treatment, Provenge. In fact, a survey conducted by Us TOO! showed that more than half of men with prostate cancer do not want to take chemotherapy.

“We believe that the FDA’s decision to delay approving a safe, effective treatment for prostate cancer patients is inhumane,” said Thomas Farrington, charter member of ProvengeNow and founder and president of PHEN. “Furthermore, we are saddened and concerned the FDA has blatantly ignored – not only its own advisory panel of experts – but the voices of the patients. We urge them to approve Provenge immediately to give patients this treatment option.”

Provenge is the first immunotherapy vaccine to complete phase III clinical trials and to demonstrate both safety and substantial efficacy for prostate cancer. An FDA advisory panel recommended the approval of Provenge; the panel voted 17 - 0 that the treatment was safe and 13 - 4 that it demonstrated substantial efficacy.

“We are disappointed and disagree with the FDA’s decision not to approve Provenge based on the overwhelming support from their expert advisory committee, and we believe this decision should be immediately revisited and evaluated,” said Dr. Mark Moyad of the University of Michigan Medical Center. Dr. Moyad, who is the Director and leader of a group of medical supporters goes on to state that, “With only one drug approved that many of these men either don’t want or cannot tolerate, why is it so difficult to understand that men with advanced prostate cancer need and deserve more and better treatment options to choose from?!”

ProvengeNow is urging prostate cancer patients, survivors, health care professionals, caregivers and anyone else who is interested in fighting cancer to join the campaign by:

Joining ProvengeNow on Capitol Hill to petition members of Congress on June 4th and 5th in Washington, D.C.
Emailing a message of support to provengenow@yahoo.com, which will be sent to the FDA
Contacting the FDA directly
Asking our members of Congress to take action
Please visit the website at www.ProvengeNow.org for more ways to take action!
About ProvengeNow:

ProvengeNow is a patient advocate initiative created to gain immediate FDA approval for the first-ever Active Cellular Immunotherapy treatment for Prostate Cancer. Survivors hope to extend their lives with a better quality with this new type of landmark treatment.

Provenge is a symbol for a new era in prostate cancer treatment.Patient advocates do not dispute the FDA’s request for more clinical data. The ProvengeNow position is that this confirmatory data should be submitted post approval and that Provenge should be approved now by the FDA for patient use.

The ProvengeNow advocate organizations support immediate approval of new prostate cancer treatments to expand the options available to patients, including Active Cellular Immunotherapy.

For more information please visit www.ProvengeNow.org.

http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20070523005808&newsLang=en

Provenge - Video Links

May 22, 2007

CNN interview W/ FDA Commissioner Andrew C. von Eschenbach, M.D.
http://video.google.com/videoplay?docid=-157504887441456856&hl=en


"Killer Bureaucracy" , FDA, Provenge, Dendreon  Fox News
http://video.google.com/videoplay?docid=2869314442027639048&hl=en



Patients Fight for Provenge. CNBC , Mike Huckman
http://video.google.com/videoplay?docid=-2167383659619688797&q=cliffhucker&hl=en


posted by cliffhucker

Update from cliffhucker -

I am sorry but Google has taken my links down due possible to copyright issues.

I have however found those and others which are at there originators websites.

Please go to my Blog @
http://provenge.blogspot.com/

And look in the post “Audio/Video Links”

Thanks!


 

traditional plants/medicines of India - new Traditional Knowledge Digital Library

http://news.bbc.co.uk/1/hi/world/south_asia/4506382.stm

The ambitious $2m project, christened Traditional Knowledge Digital Library, will roll out an encyclopaedia of the country’s traditional medicine in five languages - English, French, German, Japanese and Spanish - in an effort to stop people from claiming them as their own and patenting them.

Tulsi (holy basil)
The tulsi (holy basil) plant has medicinal qualities

The electronic encyclopaedia, which will be made available next year, will contain information on the traditional medicines, including exhaustive references, photographs of the plants and scans from the original texts.

Indian scientists say the country has been a victim of what they describe as "bio-piracy" for a long time.

"When we put out this encyclopaedia in the public domain, no one will be able to claim that these medicines or therapies are their inventions. Till now, we have not done the needful to protect our traditional wealth," says Ajay Dua, a senior bureaucrat in the federal commerce ministry.

Dr Vinod Kumar Gupta, who is leading the traditional wealth encyclopaedia project and heads India’s National Institute of Science Communication and Information Resources (Niscair), reckons that of the nearly 5,000 patents given out by the US Patent Office on various medical plants by the year 2000, some 80% were plants of Indian origin.
India has been embroiled in some high-profile patent litigation in the past decade - the government spent some $6m alone in fighting legal battles against the patenting of turmeric and neem-based medicines.

In 1995, the US Patent Office granted a patent on the wound-healing properties of turmeric.

Indian scientists protested and fought a two-year-long legal battle to get the patent revoked.

Indian curry
India got a patent on turmeric, used in curries, revoked
Last year, India won a 10-year-long battle at the European Patent Office against a patent granted on an anti-fungal product, derived from neem, by successfully arguing that the medicinal neem tree is part of traditional Indian knowledge.

In 1998 the US Patent Office granted patent to a local company for new strains of rice similar to basmati, which has been grown for centuries in the Himalayan foothills of north-west India and Pakistan and has become popular internationally. After a prolonged legal battle, the patent was revoked four years ago.

Elan/Wyeth Alzheimer’s Treatment moves into Phase III trials

May 21, 2007

 

from http://biz.yahoo.com/ap/070521/wyethelanmover.html?.v=1

AP

Wyeth, Elan Shares Jump on Study Plans
Monday May 21, 10:41 am ET

Wyeth and Elan Shares Rise on Plans for Late-Stage Study on Alzheimer’s Treatment Candidate

 

NEW YORK (AP) — Shares of drug developers Wyeth and Elan Corp. jumped Monday after the companies said they plan on asking for approval to move their Alzheimer’s treatment candidate bapineuzumab into late-stage studies.

 
The companies were waiting for Food and Drug Administration approval to move the drug candidate into Phase III clinical trials, with expectations for a start date in the second half of 2007, months ahead of the previous outlook. Results from the mid-stage, or Phase II, clinical trials aren’t expected until 2008.

….

Unlike current drugs that treat the symptoms, the new class is aimed at stopping the development of amyloid plaques in the brain and treating what is believed to be the cause of the condition.

 

ED. - Great news as it looks like the Phase II results are promising.  One step closer to another treatment for AD.

oldsters prey for telemarketers- pathetic!

 

ED.  I attended a ’seniors day’ fair some years ago and filled in a sweepstakes form.  Within a week, I was receiving phone calls from a local time-share outfit.  I complained to the organizers of the fair. 

RCMP probe US senior scams

Toronto link alleged in use of database lists to plunder cash from frail hands

May 21, 2007 04:30 AM, CHARLES DUHIGG, New York Times

The thieves operated from small offices in Toronto and hangar-size rooms in India. Every night, working from lists, they called World War II veterans, retired teachers and thousands of other elderly Americans and posed as government and insurance workers updating their files.

Then, the criminals emptied their victims’ bank accounts.

Richard Guthrie, a 92-year-old U.S. Army veteran, was one of those victims. He ended up on scam artists’ lists because his name, like millions of others, was sold by large companies to telemarketing criminals, who then turned to major banks to steal his life’s savings.

The Iowa resident had entered a few sweepstakes that caused his name to be added to a database advertised by InfoUSA, a major compiler of consumer information. InfoUSA sold data on elderly Americans to known lawbreakers, regulators say.

InfoUSA advertised lists of "Elderly Opportunity Seekers," 3.3 million elders "looking for ways to make money," and "Suffering Seniors," 4.7 million people with cancer or Alzheimer’s disease. "Oldies but Goodies" contained 500,000 gamblers over 55, for 8.5 cents apiece. One list said: "These people are gullible. They want to believe that their luck can change."

As Guthrie sat home alone - surrounded by his Purple Heart medal, photos of eight children and mementos of a wife buried nine years earlier - the telephone rang day and night.

"I loved getting those calls," he said in an interview. "Since my wife passed away, I don’t have many people to talk with. I didn’t even know they were stealing from me until everything was gone."

continued ….

InfoUSA maintains records on 210 million Americans, according to its website. In 2006, it collected more than $430 million from clients like Reader’s Digest, Publishers Clearinghouse and Condé Nast.

But InfoUSA has also sold lists to a variety of marketers with more dubious intentions, including World Marketing Service, a company that a U.S. judge shut down in 2003 for running a lottery scam.

With files from Philip Mascoll

© Copyright Toronto Star online since 1996

Vintage shops in Vancouver to check out

Smoking Lily and Front & Co.

Books I have enjoyed reading lately

Shantaram by Gregory David Roberts - set in Bombay (mostly); what a story-teller … I lauged and I cried.

see http://www.shantaram.com/ (I see that Johnny Depp has optioned the movie rights).

Sylvanus Now by Donna Morrissey (I haven’t read her other book Kit’s Law) - 1950s, set in Newfoundland, the sad story of the decline in the fish stocks and a disappearing way of life.